Your Source for Venture Capital and Private Equity Financings

SURGE Therapeutics Inks $26M Series A

2022-10-17
CAMBRIDGE, MA SURGE Therapeutics announced the completion of a $26 million Series A financing led by Camford Capital.
SURGE Therapeutics announced the completion of a $26 million Series A financing led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, and the Cancer Research Institute. The funds will be used to accelerate development of the SURGE™ intraoperative immunotherapy approach, expand the team, and initiate clinical trials for its injectable biodegradable hydrogel.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading